StonvexLoading…
StonvexStonvexStonvexCore line items from MRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $33.58K | $417.85K | $664.50K | $436.16K |
Operating Income | $-28.53M | $-65.31M | $-30.60M | $-14.88M |
Net Income | $-41.45M | $-73.88M | $-33.81M | $-14.25M |
EPS (Diluted) | $-0.53 | $-1.25 | $-0.67 | $-0.32 |
Total Assets | $29.80M | $20.38M | $40.21M | $40.88M |
Total Liabilities | $96.89M | $81.82M | $72.91M | $33.28M |
Cash & Equivalents | $7.81M | $5.15M | $19.42M | $10.50M |
Free Cash Flow OCF − CapEx | $-15.27M | $-25.41M | $-15.52M | Not available |
Shares Outstanding | 78.05M | 58.97M | 50.58M | 44.11M |